2016
DOI: 10.14309/00000434-201610001-00493
|View full text |Cite
|
Sign up to set email alerts
|

Evolution of High-resolution Manometry Parameters in Patients Who Undergo Lung Transplantation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…We found four studies reporting the specific prevalence of JE in morbidly obese patients or patients undergoing evaluation for bariatric surgery, 34‐37 six in patients with systemic sclerosis 38‐43 and four in postlung transplant patients 44‐47 (Figure 3). When compared to the prevalence of JE in the unselected general symptomatic population referred for HRM, diagnoses of JE were significantly more frequent in morbidly obese patients (5.18% [95% CI: 1.76%‐14.3%]; P = .009) and in postlung transplant patients undergoing HRM (23.99% [95% CI: 9.00%‐38.97%]; P < .001).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…We found four studies reporting the specific prevalence of JE in morbidly obese patients or patients undergoing evaluation for bariatric surgery, 34‐37 six in patients with systemic sclerosis 38‐43 and four in postlung transplant patients 44‐47 (Figure 3). When compared to the prevalence of JE in the unselected general symptomatic population referred for HRM, diagnoses of JE were significantly more frequent in morbidly obese patients (5.18% [95% CI: 1.76%‐14.3%]; P = .009) and in postlung transplant patients undergoing HRM (23.99% [95% CI: 9.00%‐38.97%]; P < .001).…”
Section: Resultsmentioning
confidence: 99%
“…We found four studies reporting the specific prevalence of JE in morbidly obese patients or patients undergoing evaluation for bariatric surgery, [34][35][36][37] six in patients with systemic sclerosis [38][39][40][41][42][43] and four in postlung transplant patients [44][45][46][47] (Figure 3 of whether or not they were symptomatic. We found Kristo et al 34 to be an influential study and once excluded the prevalence of JE in obese patients was no longer statistically superior to the unselected general population (Table S2).…”
Section: Prevalence In Specific Populationsmentioning
confidence: 99%